Affordable Access

Access to the full text

Association of Prooxidant–Antioxidant Balance with Clinical and Laboratory Parameters and Its Relation to Different Drug Regimens in Polycystic Ovary Syndrome Women with Normal BMI

Authors
  • Heshmati, Niloofar1
  • Shahgheibi, Shoaleh2
  • Nikkhoo, Bahram3
  • Amini, Sabrieh1
  • Abdi, Mohammad4, 5
  • 1 Islamic Azad University, Department of Biology, Sanandaj Branch, Sanandaj, Iran , Sanandaj (Iran)
  • 2 Kurdistan University of Medical Sciences, Department of Gynecology and Obstetrics, Faculty of Medicine, Sanandaj, Iran , Sanandaj (Iran)
  • 3 Kurdistan University of Medical Sciences, Department of Pathology, Faculty of Medicine, Sanandaj, Iran , Sanandaj (Iran)
  • 4 Kurdistan University of Medical Sciences, Cellular and Molecular Research Center, Sanandaj, Iran , Sanandaj (Iran)
  • 5 Kurdistan University of Medical Sciences, Department of Clinical Biochemistry, Faculty of Medicin, Sanandaj, Iran , Sanandaj (Iran)
Type
Published Article
Journal
Indian Journal of Clinical Biochemistry
Publisher
Springer India
Publication Date
Aug 31, 2016
Volume
32
Issue
3
Pages
315–322
Identifiers
DOI: 10.1007/s12291-016-0613-6
Source
Springer Nature
Keywords
License
Yellow

Abstract

Polycystic ovarian syndrome is one of the most common hormonally leading cause infertility disorders. The effect of oxidant-antioxidant imbalance on disease progression has been studied in many disorders. The present study was aimed to evaluate prooxidant–antioxidant balance (PAB) in patients with polycystic ovarian syndrome compared to healthy subjects. We also studied the possible effect of treatment with available drugs on serum PAB. In this case–control study 100 polycystic ovary syndrome (PCOS) patients and 100 healthy individuals were enrolled in the study. The laboratory features of patients and controls like as serum LH and FSH concentration and hematological examinations were collected. PAB was evaluated by a colorimetric method. Serum PAB value was significantly higher before treatment compared to after treatment and healthy subjects. PAB values were also higher in subjects with irregular menstrual cycle compared to normal subjects. Our results represented that serum PAB values has an indirect significant correlation with serum LH concentration. We also found that drugs regimen containing spironolactone effectively reduced the serum PAB values. Our results showed that PCOS patients had increased level of PAB and treatment with spironolactone mainly decreases the level of serum PAB. Our results indicate that the measurements of PAB may be used as a potential laboratory marker for assessment of PCOS patients.

Report this publication

Statistics

Seen <100 times